ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 8 of 309 for:    complementary and alternative medicine

The Application of Evidence-Based Chinese Complementary and Alternative Medicine (CAM) in Hospice Palliative Care in Taiwan

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02663063
Recruitment Status : Unknown
Verified January 2016 by Taipei Veterans General Hospital, Taiwan.
Recruitment status was:  Enrolling by invitation
First Posted : January 26, 2016
Last Update Posted : February 2, 2016
Sponsor:
Information provided by (Responsible Party):
Taipei Veterans General Hospital, Taiwan

Brief Summary:
The study aims to explore the effects of silver spike point (SSP) treatment on common symptoms including pain, breathlessness, nausea/vomiting, dry mouth etc. of terminal cancer patients.

Condition or disease Intervention/treatment Phase
Cancer Device: SSP treatment Not Applicable

Detailed Description:
The study aims to explore the effects of silver spike point treatment on common symptoms including pain, breathlessness, nausea/vomiting, dry mouth etc. of terminal cancer patients. We will conducted a pilot study to evaluate the effects on different symptoms and then a prospective study will be conducted after validation of major effects.

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 494 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Supportive Care
Official Title: The Application of Evidence-Based Chinese Complementary and Alternative Medicine (CAM) in Hospice Palliative Care in Taiwan-The Second and Third Year Project.
Study Start Date : December 2015
Estimated Primary Completion Date : October 2016
Estimated Study Completion Date : October 2016

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: SSP treatment group
Case on SSP treatment
Device: SSP treatment
SSP treatment 5 times a week

Sham Comparator: Non-SSP treatment group
Sham SSP treatment
Device: SSP treatment
SSP treatment 5 times a week




Primary Outcome Measures :
  1. Symptom severity score [ Time Frame: One week after treatment ]
    Questionnaire for evaluating the severity of symptoms


Secondary Outcome Measures :
  1. Quality of life [ Time Frame: One week after treatment ]
    Questionnaire for evaluating quality of life



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 90 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Cancer patients
  • Competent with clear consciousness
  • With symptoms of pain, breathlessness, nause/vomiting, dry mouth, generalized discomfort
  • Expected life span of at least 1 week

Exclusion Criteria:

  • With implanted devices
  • Not having clear consciousness
  • Expected life span less than 1 week
  • Foreigner

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02663063


Locations
Taiwan
Taipei Veterans General Hospital
Taipei, Taiwan, 11217
Sponsors and Collaborators
Taipei Veterans General Hospital, Taiwan
Investigators
Principal Investigator: Shinn-Jang Hwang, MD Taipei Veterans General Hospital, Taipei, Taiwan

Publications:

Responsible Party: Taipei Veterans General Hospital, Taiwan
ClinicalTrials.gov Identifier: NCT02663063     History of Changes
Other Study ID Numbers: 2015-10-005A
First Posted: January 26, 2016    Key Record Dates
Last Update Posted: February 2, 2016
Last Verified: January 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided
Plan Description: Undecided

Keywords provided by Taipei Veterans General Hospital, Taiwan:
Complementary and alternative medicine
Hospice Palliative Care